PubMed

Prostate-specific antigen testing accuracy in community practice.

Hoffman RM, Gilliland FD, Adams-Cameron M, Hunt WC, Key CR.

BMC Fam Pract. 2002 Oct 24;3:19. Epub 2002 Oct 24.PMID: 12398793 [PubMed - indexed for MEDLINE]Related articlesFree article

Using multiple cutpoints for the free-to-total prostate specific antigen ratio improves the accuracy of prostate cancer detection.

Hoffman RM, Clanon DL, Chavez M, Peirce JC.

Prostate. 2002 Jul 1;52(2):150-8.PMID: 12111706 [PubMed - indexed for MEDLINE]Related articles

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

Thompson IM, Ankerst DP, Chi C, Lucia MS, Goodman PJ, Crowley JJ, Parnes HL, Coltman CA Jr.

JAMA. 2005 Jul 6;294(1):66-70.PMID: 15998892 [PubMed - indexed for MEDLINE]Related articlesFree article

Age-specific reference ranges for prostate-specific antigen in black men.

Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW.

N Engl J Med. 1996 Aug 1;335(5):304-10.PMID: 8663870 [PubMed - indexed for MEDLINE]Related articlesFree article

Utility of volume adjusted prostate specific antigen density in the diagnosis of prostate cancer in Arab men.

Sheikh M, Al-Saeed O, Kehinde EO, Sinan T, Anim JT, Ali Y.

Int Urol Nephrol. 2005;37(4):721-6.PMID: 16362587 [PubMed - indexed for MEDLINE]Related articles

Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.

Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM.

N Engl J Med. 2003 Jul 24;349(4):335-42.PMID: 12878740 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictive properties of serum-prostate-specific antigen testing in a community-based setting.

Jacobsen SJ, Bergstralh EJ, Guess HA, Katusic SK, Klee GG, Oesterling JE, Lieber MM.

Arch Intern Med. 1996 Nov 25;156(21):2462-8.PMID: 8944739 [PubMed - indexed for MEDLINE]Related articles

Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer.

Ito K, Yamamoto T, Kubota Y, Suzuki K, Fukabori Y, Kurokawa K, Yamanaka H.

Urology. 2000 Aug 1;56(2):278-82.PMID: 10925094 [PubMed - indexed for MEDLINE]Related articles

[Value of prostate-specific antigen density and transitional-zone prostate-specific antigen density in the diagnosis of prostate cancer]

Martínez Jabaloyas JM, García Morata F, Villamón Fort R, Pastor Hernández F, Gil Salom M, García Sisamón F.

Actas Urol Esp. 2003 Jun;27(6):442-9. Spanish. PMID: 12918151 [PubMed - indexed for MEDLINE]Related articlesFree article

Values for free/total prostate-specific antigen ratio as a function of age: necessity of reference validation in a Turkish population.

Mungan AG, Erol B, Akduman B, Bozdogan G, Kiran S, Yesilli C, Mungan NA.

Clin Chem Lab Med. 2007;45(7):912-6. Erratum in: Clin Chem Lab Med. 2007;45(11):1570. PMID: 17617037 [PubMed - indexed for MEDLINE]Related articles

Usefulness of prostate-specific antigen velocity in screening for prostate cancer.

Ito K, Yamamoto T, Ohi M, Kubota Y, Fukabori Y, Kurokawa K, Suzuki K, Yamanaka H.

Int J Urol. 2002 Jun;9(6):316-21.PMID: 12110095 [PubMed - indexed for MEDLINE]Related articles

Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer.

Okihara K, Cheli CD, Partin AW, Fritche HA, Chan DW, Sokoll LJ, Brawer MK, Schwartz MK, Vessella RL, Loughlin KR, Johnston DA, Babaian RJ.

J Urol. 2002 May;167(5):2017-23; discussion 2023-4.PMID: 11956430 [PubMed - indexed for MEDLINE]Related articles

Receiver operating characteristics of the prostate specific antigen test in an unselected population.

McLernon DJ, Donnan PT, Gray M, Weller D, Sullivan F.

J Med Screen. 2006;13(2):102-7.PMID: 16792835 [PubMed - indexed for MEDLINE]Related articles

Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years.

Sun L, Moul JW, Hotaling JM, Rampersaud E, Dahm P, Robertson C, Fitzsimons N, Albala D, Polascik TJ.

BJU Int. 2007 Apr;99(4):753-7. Epub 2007 Jan 19.PMID: 17244286 [PubMed - indexed for MEDLINE]Related articles

Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL.

Okegawa T, Kinjo M, Ohta M, Miura I, Horie S, Nutahara K, Higashihara E.

Int J Urol. 2003 Apr;10(4):201-6.PMID: 12657099 [PubMed - indexed for MEDLINE]Related articles

A prospective study to evaluate the role of complexed prostate specific antigen and free/total prostate specific antigen ratio for the diagnosis of prostate cancer.

Mitchell ID, Croal BL, Dickie A, Cohen NP, Ross I.

J Urol. 2001 May;165(5):1549-53.PMID: 11342915 [PubMed - indexed for MEDLINE]Related articles

Prostate-specific antigen (PSA) complexed to alpha1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL.

Kobayashi T, Kamoto T, Nishizawa K, Mitsumori K, Ogura K, Ide Y.

BJU Int. 2005 Apr;95(6):761-5.PMID: 15794778 [PubMed - indexed for MEDLINE]Related articles

Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL.

Kobayashi T, Mitsumori K, Kawahara T, Nishizawa K, Ogura K, Ide Y.

Int J Urol. 2005 Nov;12(11):969-75.PMID: 16351653 [PubMed - indexed for MEDLINE]Related articles

Measurement of serum zinc improves prostate cancer detection efficiency in patients with PSA levels between 4 ng/mL and 10 ng/mL.

Li XM, Zhang L, Li J, Li Y, Wang HL, Ji GY, Kuwahara M, Zhao XJ.

Asian J Androl. 2005 Sep;7(3):323-8.PMID: 16110361 [PubMed - indexed for MEDLINE]Related articlesFree article

Predicting the outcome of prostate biopsy in a racially diverse population: a prospective study.

Porter CR, O'Donnell C, Crawford ED, Gamito EJ, Sentizimary B, De Rosalia A, Tewari A.

Urology. 2002 Nov;60(5):831-5.PMID: 12429310 [PubMed - indexed for MEDLINE]Related articles